COX5A and pulmonary arterial hypertension: Previous reports showed that down-regulation of COX5A significantly decreases COX activity, leading to mitochondrial dysfunction, pulmonary arterial hypertension, lactic academia, hypoglycemia, growth delay, and failure to thrive [18,19].